loader image

Recent Lectureships

 

2025

Maura Corsetti, MD, PHD

Intersecting Pathways: Exploring the Clinical and Pathophysiological overlap between IBS and IBD?

Charles Bernstein, MD

Clinical Challenges and Management strategies: addressing the overlap of IBS & IBD?

2024

Andrea Shin, MD, MSCR

What is the evidence of gut microbiota testing?

Stephen Vanner, MD, MSCR

What is the evidence for food sensitivity testing?
Magnus Simrén, MD, PhD Research Director

Magnus Simrén, MD, PhD

What are the relationships between diets and gut microbiome and their impact on symptoms?

2023

Madhusudan Grover, MBBS

Madhusan Grover, MD, AGAF

Mechanistic Evidence for Altered Intestinal Permeability in Food Sensitivities, Functional Dyspepsia, and IBS

Tim Vanuytsel, MD, PhD

Can we Measure Intestinal Permeability in Clinical Research and Practice?

Lin Chang, MD

Implications of Targeting Intestinal Permeability on Clinical Symptoms and Potential Treatments for DGBI

2022

Giovanni Barbara, MD

Giovanni Barbara, MD

Post-COVID IBS and other DGBI: Prevalence, Incidence and Symptom Impact
Sarah Ballou, PhD

Sarah Ballou, PhD

Psychosocial impact of COVID in Patients with DGBI

2021

Keith A. Sharkey

Keith A Sharkey, PhD, CAGF

Endocannabinoid System and Its Mechanistic Role In Nausea and Vomiting and Chronic Abdominal Pain
Thangam Venkatesan

Thangam Venkatesan, MD

Beneficial and Adverse Effects of Cannabinoids on Functional GI Disorders and Symptoms